Breakthrough Study: Ozempic and GLP-1 Drugs Shown to Reduce Risk of 42 Health Conditions
2025-01-20AOL
A groundbreaking study of nearly 2 million patients, the largest of its kind, has revealed that Ozempic and GLP-1 receptor agonists can significantly lower the risk of 42 health conditions, including heart attacks, Alzheimer's disease, and other chro ...Read more
Recommendations